Skip to content

Drug interactions

Dabigatran etexilate + Vorapaxar

Severity: Major

Dabigatran etexilate and Vorapaxar: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vorapaxar is a PAR-1 antiplatelet with a long half-life and combining it with an anticoagulant raises the risk of major bleeding, including intracranial hemorrhage.

What this interaction means in plain words

Dabigatran etexilate and Vorapaxar can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive effects on hemostasis: PAR-1 platelet inhibition combined with thrombin inhibition.

What to do

Avoid unless clearly indicated; vorapaxar is contraindicated with prior stroke or intracranial hemorrhage. Monitor for bleeding and hemoglobin.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabigatran etexilate and Vorapaxar, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabigatran etexilate with Vorapaxar?

MediHelp rates the interaction as major. Dabigatran etexilate and Vorapaxar can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Vorapaxar is a PAR-1 antiplatelet with a long half-life and combining it with an anticoagulant raises the risk of major bleeding, including intracranial hemorrhage.

How serious is the interaction between Dabigatran etexilate and Vorapaxar?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid unless clearly indicated; vorapaxar is contraindicated with prior stroke or intracranial hemorrhage. Monitor for bleeding and hemoglobin.

What other medicines interact with Dabigatran etexilate?

MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in